We hypothesized that pretreatment of NQO1-overexpressing PDA cells with FK866 would sensitize them to subsequent β-lap exposure by lowering the available NAD+ pools, thereby increasing the ability of PARP1 to deplete the remaining NAD+ when stimulated by NQO1-induced ROS generation. This evidence concerns the gene NQO1 and Patent ductus arteriosus.